Ethyl 3-amino-4-(methylamino)benzoate(CAS: 66315-23-9)

Ethyl 3-amino-4-(methylamino)benzoate (CAS: 66315-23-9) falls under the scrutiny of various regulatory guidelines. Under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), it is classified as a skin and eye irritant. For production and import, the European Union's REACH regulations apply, requiring registration for substances above 1 tonne per year. The U.S. FDA may regulate it for pharmaceutical use, while the EPA oversees its environmental impact and disposal methods.

Yes, there are alternatives to Ethyl 3-amino-4-(methylamino)benzoate (CAS: 66315-23-9) in synthesis. Analogous compounds such as Ethyl 3-amino-4-(ethylamino)benzoate and Ethyl 3-hydroxy-4-(methylamino)benzoate can be used. Common alternative reagents include N-methylmorpholine and triethylamine. These alternatives can offer similar functional groups or different properties depending on specific synthetic needs.

The market for Ethyl 3-amino-4-(methylamino)benzoate (CAS: 66315-23-9) reflects growing interest in its use as a dermatological agent due to its skin and eye irritant properties. Research trends indicate a focus on its safety and efficacy in topical applications. There is also increasing exploration of its potential in pharmaceuticals, particularly in the development of new drug delivery systems and anti-inflammatory treatments.

Waste containing Ethyl 3-amino-4-(methylamino)benzoate (CAS: 66315-23-9) should be collected and stored in sealed, leak-proof containers. Proper incineration or professional waste disposal services should be utilized to ensure safe disposal. Environmental precautions include the use of personal protective equipment (PPE) and adherence to local regulations to minimize environmental impact. Safe handling and disposal practices are crucial for protecting both human health and the environment.